Maplirpacept Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PF-07901801, TTI-622

Filter by location:

Little Rock, Arkansas1 trial

A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma

University of Arkansas for Medical Sciences

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.